UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3876
Smith & Nephew
SNN
$13B
| $6.51M | ﹤0.01% |
226,086
-100,218
| -31% | -$3.11M |
2014 Q4
46 quarters
|
|
3877
PIMCO High Income Fund
PHK
$773M
| $6.5M | ﹤0.01% |
1,395,218
+129,275
| +10% | +$596K |
2014 Q4
46 quarters
|
|
3878
ProShares Short S&P500
SH
$984M
| $6.5M | ﹤0.01% |
196,849
-422,604
| -68% | -$14.5M |
2014 Q4
46 quarters
|
|
3879
Accelerant Holdings
ARX
$4.32B
| $6.5M | ﹤0.01% |
554,448
-131,199
| -19% | -$1.84M |
2025 Q3
3 quarters
|
|
3880
PUT
Equinix
EQIX
$100B
| $6.46M | ﹤0.01% |
6,200
-2,500
| -29% | -$2.68M |
2025 Q1
5 quarters
|
|
3881
Teekay
TK
$1.11B
| $6.43M | ﹤0.01% |
643,135
-135,256
| -17% | -$1.69M |
2014 Q4
46 quarters
|
|
3882
Addus HomeCare
ADUS
$2.32B
| $6.42M | ﹤0.01% |
63,877
-12,172
| -16% | -$1.15M |
2018 Q2
32 quarters
|
|
3883
ATS Corp
ATS
$1.63B
| $6.41M | ﹤0.01% |
222,553
-5,075
| -2% | -$156K |
2023 Q2
12 quarters
|
|
3884
CALL
Oklo
OKLO
$4.38B
| $6.4M | ﹤0.01% |
122,258
-24,400
| -17% | -$1.52M |
2025 Q3
3 quarters
|
|
3885
MoonLake Immunotherapeutics
MLTX
$981M
| $6.4M | ﹤0.01% |
328,522
+324,643
| +8,369% | +$5.88M |
2023 Q3
11 quarters
|
|
3886
Alpha and Omega Semiconductor
AOSL
$716M
| $6.4M | ﹤0.01% |
135,116
-53,624
| -28% | -$2.15M |
2018 Q2
32 quarters
|
|
|
KARD
3887
Kardigan Inc
KARD
$1.45B
| $6.39M | ﹤0.01% |
+267,760
| New | +$6.19M |
2026 Q2
0 quarters
|
|
3888
QuinStreet
QNST
$1.18B
| $6.39M | ﹤0.01% |
435,883
-34,407
| -7% | -$432K |
2014 Q4
46 quarters
|
|
3889
Knowles
KN
$2.65B
| $6.37M | ﹤0.01% |
153,622
-202,406
| -57% | -$7.03M |
2014 Q4
46 quarters
|
|
3890
CALL
Kinross Gold
KGC
$26.2B
| $6.37M | ﹤0.01% |
269,574
| – | – |
2025 Q4
2 quarters
|
|
3891
Napco Security Technologies
NSSC
$1.08B
| $6.35M | ﹤0.01% |
167,284
+116,516
| +230% | +$4.63M |
2017 Q1
37 quarters
|
|
3892
Nuvation Bio
NUVB
$1.47B
| $6.34M | ﹤0.01% |
1,116,881
-257,066
| -19% | -$1.26M |
2023 Q1
13 quarters
|
|
3893
BlackRock MuniYield New York Quality Fund
MYN
$885M
| $6.32M | ﹤0.01% |
623,072
+6,835
| +1% | +$67.9K |
2014 Q4
46 quarters
|
|
3894
ZIM Integrated Shipping Services
ZIM
$3.37B
| $6.32M | ﹤0.01% |
243,134
+81,030
| +50% | +$2.09M |
2021 Q1
21 quarters
|
|
3895
Allogene Therapeutics
ALLO
$359M
| $6.32M | ﹤0.01% |
3,038,392
+1,434,302
| +89% | +$3.15M |
2018 Q4
30 quarters
|
|
3896
CALL
Polaris
PII
$3.59B
| $6.31M | ﹤0.01% |
92,200
+44,900
| +95% | +$2.89M |
2025 Q2
4 quarters
|
|
3897
PUT
Edwards Lifesciences
EW
$58.7B
| $6.31M | ﹤0.01% |
69,700
-100,900
| -59% | -$8.45M |
2025 Q2
4 quarters
|
|
3898
Openlane
OPLN
$4.17B
| $6.3M | ﹤0.01% |
152,806
+63,786
| +72% | +$2.23M |
2014 Q4
46 quarters
|
|
3899
iShares MSCI France ETF
EWQ
$352M
| $6.3M | ﹤0.01% |
138,676
+97,580
| +237% | +$4.43M |
2014 Q4
46 quarters
|
|
3900
Vanguard Short-Term Tax-Exempt Bond ETF
VTES
$3.73B
| $6.3M | ﹤0.01% |
62,184
+16,845
| +37% | +$1.7M |
2023 Q3
11 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.